Highest-materiality recent filing
Trulieve authorizes up to $50M share repurchase program for up to 5% of outstanding shares
Board authorized repurchase up to lesser of $50 million or 8,495,038 subordinate voting shares (5% of outstanding as of June 8, 2026) over 12 months.
Trulieve deconsolidates Harvest mixed-use business; records $688.7M loss, receives $14.8M investment
Effective June 3, 2026: Harvest (mixed-use cannabis) deconsolidated from Trulieve to segregate medical cannabis for NYSE listing application.
Trulieve Q1 2026: Revenue $287M, Net Income $2M, Adjusted EBITDA $100M, Gross Margin 59%
Q1 revenue $287M; gross margin 59% ($170M gross profit); 92% of revenue from retail sales.
Trulieve reports FY2025 revenue $1.2B, 60% gross margin, record operating cash flow $273M
Record FY2025 revenue $1.2B; 60% gross margin; adjusted EBITDA $427M (36% of revenue).
Trulieve closes $140M private placement of 10.5% senior secured notes due 2030
$140M aggregate principal of 10.5% senior secured notes due Dec 17, 2030 closed; size increased due to demand.
Trulieve raises $100M via 10.5% senior secured notes due 2030
Gross proceeds of $100M from private placement of 10.5% Senior Secured Notes.
Trulieve Q3 revenue $288M, gross margin 59%, adjusted EBITDA $103M
Revenue of $288M, 94% from retail; GAAP gross profit $170M (59% margin).
Trulieve calls all $368M of 8% Notes due 2026; redemption Dec 5, 2025
Aggregate principal of US$368,000,000 in 8.0% senior secured notes due 2026 to be redeemed.
Trulieve appoints Matthew Foulston to board and Jan Reese as CFO, effective Sept 8, 2025
Matthew Foulston appointed to Trulieve board; former CFO of Covetrus, TreeHouse Foods, and Compass Minerals.
Trulieve Q2 revenue $302M, adjusted EBITDA $111M (37% of revenue), net loss $14M
Revenue $302M comparable to prior year; gross margin 61% vs 60% in Q2 2024.
Trulieve Q1 revenue $298M, gross margin 62%, adjusted EBITDA $109M
Q1 revenue of $298M, slightly up YoY; 95% from retail sales.
Trulieve CFO Wes Getman resigns; VP Finance Ryan Blust named interim CFO
Wes Getman resigned as CFO effective March 6, 2025, to pursue other opportunities; no severance paid.
Trulieve Q4 revenue $301M (+5% YoY), gross margin 62%; FY2024 record FCF $150M
Q4 2024 revenue $301M, up 5% YoY; gross margin 62% vs 54% in Q4 2023.
Trulieve Q3 revenue $284M, gross margin 61%; $48M campaign spend drives net loss $60M
Revenue $284M (+3% YoY); gross margin 61% vs 52% in Q3 2023; adjusted EBITDA $96M (34% revenue), up 24% YoY.
Trulieve Q2 revenue $303M up 8% YoY; gross margin 60%; launches Ohio adult-use sales
Revenue of $303M (+2% seq, +8% YoY); 95% from retail; gross profit $182M (60% margin).
Trulieve Q1 2024 revenue $298M, up 4% sequentially; adjusted EBITDA $106M
Revenue of $298M (+4% sequentially & YoY); 58% GAAP gross margin on $174M gross profit.
Dismissed Marcum LLP effective March 25, 2024; engaged WithumSmith+Brown, PC as auditor for FY2024.
Trulieve Q4 revenue $287M (+4% seq); expects 2024 op cash flow at least $225M
Q4 rev $287M (+4% sequentially); GAAP gross margin 54%; net loss $33M, adj net loss $23M.
Trulieve completes redemption of all US$130M 9.75% senior secured notes due 2024
Redeemed all US$130M (C$175.7M) principal of 9.75% senior secured notes due 2024.
Trulieve Q3: $275M revenue, $93M operating cash flow, net loss $25M, cuts debt
Revenue $275M, GAAP gross margin 52%, net loss $25M, adj. net loss $15M.
Trulieve files amended tax returns seeking $143M refund citing 280E challenge
Filed amended federal returns for 2019, 2020 and 2021 claiming a $143M refund.
Trulieve repurchases 57,000 senior secured notes at 16.5% discount for $47.6M
Purchased 57,000 notes (face value $1,000 each) due Oct 6, 2026, for $47.6M plus accrued interest.
Trulieve Q2 revenue $282M, net loss $404M on goodwill impairment; exits CA/MA
Revenue $282M (96% retail); GAAP gross margin 50%; SG&A down $4M sequentially to $96M.
Trulieve CFO Tim Mullany departs; Ryan Blust appointed interim CFO
Tim Mullany resigned as CFO effective July 20, 2023 for personal reasons; no severance paid.
Tim Mullany appointed Trulieve CFO effective July 10, 2023; Alex D'Amico resigns
Tim Mullany appointed CFO effective July 10, 2023; succeeds Alex D'Amico who resigned immediately with no severance.
Trulieve Q1 2023 revenue $289M, net loss $64M, adjusted EBITDA $78M
Revenue of $289M (95% retail); GAAP gross margin 52%, gross profit $150M.
Trulieve reports record FY2022 revenue of $1.24B, Q4 net loss of $77M
FY2022 revenue $1.24B (+32% YoY); Q4 revenue $302M, 2% sequential retail growth.
Trulieve closes $71.5M secured loan at 7.53% fixed rate for five years
Loan of $71.5M secured by cultivation/manufacturing site in Monticello, Florida.
Trulieve Q3 revenue $301M (+34% YoY); net loss $115M with $93M impairments; adj. EBITDA $99M
Revenue $301M (+34% YoY); 94% retail; GAAP gross margin 56%, gross profit $168M.
Trulieve reports record Q2 revenue of $320.3M, up 49% YoY; adjusted EBITDA margin 35%
Revenue $320.3M, up 49% YoY and 1% sequentially; retail revenue $298.6M (+3% QoQ).
Trulieve Q1 2022 revenue $318.3M, up 64% YoY; adjusted EBITDA $105.5M
Revenue $318.3M (+64% YoY, +4% sequentially); GAAP gross margin 56.0% vs 43.4% in Q4 2021.
On June 11, 2026 (the “Termination Date”), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective immediately.
The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.
On March 6, 2025, Wes Getman resigned from his position as Chief Financial Officer of Trulieve Cannabis Corp. (the “Company”) to pursue other opportunities.
On April 17, 2024, Giannella Alvarez gave notice that she will not be standing for reelection to the board of directors at the annual general and special meeting of the shareholders of Trulieve Cannabis Corp. (the "Company") to be held June 12, 2024.
On January 12, 2024, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Marie Zhang as the Company’s Chief Operating Officer, effective January 29, 2024.
On December 22, 2023, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Wes Getman as the Company’s Chief Financial Officer, effective January 1, 2024.
Ryan Blust will no longer serve as Interim Chief Financial Officer but will remain as the Company’s Vice President, Finance.
The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.
On July 21, 2023, Trulieve Cannabis Corp. (the “Company”) announced the departure of Tim Mullany as Chief Financial Officer, for personal reasons and effective July 20, 2023.
the Company appointed Timothy Mullany as its Chief Financial Officer, effective as of July 10, 2023
the Company has appointed Ryan Blust, the Company’s Vice President, Finance, to serve as its Interim Chief Financial Officer, effective immediately
Mr. D’Amico’s resignation as Chief Financial Officer was effective immediately.
Max materiality 0.80 · Median 0.65 · Most common event earnings